These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 10438725

  • 1. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus.
    Subklewe M, Chahroudi A, Schmaljohn A, Kurilla MG, Bhardwaj N, Steinman RM.
    Blood; 1999 Aug 15; 94(4):1372-81. PubMed ID: 10438725
    [Abstract] [Full Text] [Related]

  • 2. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E.
    Proc Natl Acad Sci U S A; 1990 Apr 15; 87(8):2906-10. PubMed ID: 2158098
    [Abstract] [Full Text] [Related]

  • 3. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.
    Gottschalk S, Edwards OL, Sili U, Huls MH, Goltsova T, Davis AR, Heslop HE, Rooney CM.
    Blood; 2003 Mar 01; 101(5):1905-12. PubMed ID: 12411306
    [Abstract] [Full Text] [Related]

  • 4. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 5. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.
    Yang S, Kittlesen D, Slingluff CL, Vervaert CE, Seigler HF, Darrow TL.
    J Immunol; 2000 Apr 15; 164(8):4204-11. PubMed ID: 10754316
    [Abstract] [Full Text] [Related]

  • 7. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426
    [Abstract] [Full Text] [Related]

  • 8. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB.
    J Exp Med; 1992 Jul 01; 176(1):157-68. PubMed ID: 1319456
    [Abstract] [Full Text] [Related]

  • 9. Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytes.
    Subklewe M, Chahroudi A, Bickham K, Larsson M, Kurilla MG, Bhardwaj N, Steinman RM.
    Eur J Immunol; 1999 Dec 01; 29(12):3995-4001. PubMed ID: 10602009
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
    Keever-Taylor CA, Margolis D, Konings S, Sandford GR, Nicolette CA, Lawendowski C, Burns WH.
    Biol Blood Marrow Transplant; 2001 Dec 01; 7(5):247-56. PubMed ID: 11400946
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M, Benninger-Döring G, Prang N, Sylla BS, Laumbacher B, Wank R, Wolf H, Schwarzmann F.
    Int J Cancer; 1998 May 29; 76(5):694-701. PubMed ID: 9610728
    [Abstract] [Full Text] [Related]

  • 12. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C, Burrows SR, Sculley TB, Moss DJ, Misko IS.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9478-82. PubMed ID: 1719531
    [Abstract] [Full Text] [Related]

  • 13. Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells.
    Mukherjee S, Trivedi P, Dorfman DM, Klein G, Townsend A.
    J Exp Med; 1998 Feb 02; 187(3):445-50. PubMed ID: 9449725
    [Abstract] [Full Text] [Related]

  • 14. Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.
    Khanna R, Jacob CA, Burrows SR, Kurilla MG, Kieff E, Misko IS, Sculley TB, Moss DJ.
    Immunology; 1991 Nov 02; 74(3):504-10. PubMed ID: 1722774
    [Abstract] [Full Text] [Related]

  • 15. Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
    Zarling JM, Moran PA, Lasky LA, Moss B.
    J Virol; 1986 Aug 02; 59(2):506-9. PubMed ID: 3016312
    [Abstract] [Full Text] [Related]

  • 16. Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection.
    Khanna R, Jacob CA, Burrows SR, Moss DJ.
    J Immunol Methods; 1993 Aug 26; 164(1):41-9. PubMed ID: 7689619
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma.
    Wheatley GH, McKinnon KP, Iacobucci M, Mahon S, Gelber C, Lyerly HK.
    Surgery; 1998 Aug 26; 124(2):171-6. PubMed ID: 9706135
    [Abstract] [Full Text] [Related]

  • 18. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 26; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 19. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z, Moutaftsi M, Borysiewicz LK.
    J Immunol; 2001 May 01; 166(9):5695-703. PubMed ID: 11313411
    [Abstract] [Full Text] [Related]

  • 20. Mature CD83(+) dendritic cells infected with recombinant gp100 vaccinia virus stimulate potent antimelanoma T cells.
    Prabakaran I, Menon C, Xu S, Gómez-Yafal A, Czerniecki BJ, Fraker DL.
    Ann Surg Oncol; 2002 May 01; 9(4):411-8. PubMed ID: 11986195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.